These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22446621)

  • 1. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
    Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
    Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
    Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
    J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
    Gui T; Cao D; Shen K; Yang J; Zhang Y; Yu Q; Wan X; Xiang Y; Xiao Y; Guo L
    Gynecol Oncol; 2012 Nov; 127(2):384-9. PubMed ID: 22850410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Frigerio L; Candiani M; Savarese A; Giorda G; Lauria R; Tamberi S; Greggi S; Lorusso D
    Gynecol Oncol; 2013 Jul; 130(1):38-42. PubMed ID: 23623833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 11 cases of ovarian Setoli-Leydig cell tumor].
    Li B; Wu LY; Zhang WH; Li L; Ma SK; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):334-7. PubMed ID: 15196418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
    Bhat RA; Lim YK; Chia YN; Yam KL
    J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
    Zhang HY; Zhu JE; Huang W; Zhu J
    Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Sertoli-Leydig cell tumor: a report of seven cases and a review of the literature.
    Xiao H; Li B; Zuo J; Feng X; Li X; Zhang R; Wu L
    Gynecol Endocrinol; 2013 Mar; 29(3):192-5. PubMed ID: 23173550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
    Wang G; Zhang R; Li C; Chen A
    J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
    Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
    Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.
    Harrison ML; Hoskins P; du Bois A; Quinn M; Rustin GJ; Ledermann JA; Baron-Hay S; Friedlander ML
    Gynecol Oncol; 2006 Feb; 100(2):233-8. PubMed ID: 16321429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.
    Uzan C; Morice P; Rey A; Pautier P; Camatte S; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
    Ann Surg Oncol; 2004 Jul; 11(7):658-64. PubMed ID: 15197013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian immature teratoma: treatment and outcome in a single institutional cohort.
    Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.